Stempeutics Research Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
- Paid Up Capital ₹ 59.67 Cr
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.18 Cr
- Revenue Growth 357.64%
- Profit Growth 49.71%
- Ebitda -41.07%
- Net Worth 52.97%
- Total Assets 5.03%
About Stempeutics Research
Stempeutics Research Private Limited (SRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 January 2006 and has a history of 19 years and two months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 59.67 Cr.
The company currently has active open charges totaling ₹2.18 Cr.
The Key Managerial Personnel (KMP) at Stempeutics Research Private Limited India is Kriti Agarwal as COMPANY SECRETARY. Anurag Bagaria, Manohar Narasimhan, Hebri Ballal, and Two other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100KA2006PTC038256
- Company No.
038256
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2006
- Date of AGM
19 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Life Sciences
What products or services does Stempeutics Research Private Limited offer?
Stempeutics Research Private Limited offers a wide range of products and services, including Natural Therapy Services, Stem Cell Therapy, Dermatology Treatment Services, Medical Surgery & Treatment Centres, Medical Facilities, Medical Equipment & Accessories, Life Support Machines, Hospital Equipment.
Stempeutics Research Private Limited
Explore comprehensive data for Stempeutics Research Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Stempeutics Research?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manohar Narasimhan  | Managing Director | 26-Aug-2009 | Current |
| Kriti Agarwal | Company Secretary | 21-Mar-2023 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umang Vohra | Director | 03-Jan-2024 | Current |
| Anurag Bagaria | Director | 27-Jun-2019 | Current |
| Hebri Ballal | Director | 19-Jan-2012 | Current |
| Jaideep Gogtay | Nominee Director | 05-Jun-2011 | Current |
Financial Performance of Stempeutics Research.
Stempeutics Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 357.64% increase. The company also saw a substantial improvement in profitability, with a 49.71% increase in profit. The company's net worth Soared by an impressive increase of 52.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stempeutics Research?
In 2023, Stempeutics Research had a promoter holding of 46.49% and a public holding of 53.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Manipal Hospitals Private LimitedHebri Ballal is a mutual person
- Manipal Hospitals (Bengaluru) Private Limited
Hebri Ballal is a mutual person
- Manipal Health Enterprises Private Limited
Hebri Ballal is a mutual person
- Manipal Hospitals (Dwarka) Private Limited
Hebri Ballal is a mutual person
North Bengal Clinic Pvt LtdHebri Ballal is a mutual person
Manipal Hospitals (East) India Private LimitedHebri Ballal is a mutual person
Charges (Loans)
Open Charges
₹2.18 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Biotechnology Industry Research Assistance Council : 1.89 Cr
- Hdfc Bank Limited : 0.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2021 | Hdfc Bank Limited | ₹2.84 M | Open |
| 31 Dec 2011 | Biotechnology Industry Research Assistance Council | ₹1.89 Cr | Open |
How Many Employees Work at Stempeutics Research?
Stempeutics Research has a workforce of 27 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stempeutics Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stempeutics Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Stempeutics Research
Recent activity within the organization
- Annual General Meeting
Stempeutics Research Private Limited last Annual general meeting of members was held on 19 Jul 2024 as per latest MCA records.
- Balance Sheet
Stempeutics Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Director Appointment
Umang Vohra was appointed as a Director was appointed as a Director on 03 Jan 2024 & has been associated with this company since 1 year 3 months .
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.28 Cr with Charge ID 100506817 was registered on 19 Nov 2021.
- Director Appointment
Anurag Bagaria was appointed as a Director was appointed as a Director on 27 Jun 2019 & has been associated with this company since 5 years 9 months .
- Charges
A charge with Biotechnology Industry Research Assistance Council of Rs. 1.89 Cr registered on 31 Dec 2011 with Charge ID 10337194 was modified on 10 Jun 2015.
Recent News, Updates & Announcement
- Revolutionary Stem Cell Drug Offers Hope for Non-Healing Diabetic Foot Ulcers in Phase 3 Trial.
When you have a non-healing diabetic foot ulcer, the current treatments may not work and can even lead to amputation. But Stempeucel-DFU, a new drug being tested in a Phase 3 trial, could change that. It's made from stem cells and could help heal the ulcer and reduce its size. If it works, it could make a big difference for patients and improve their quality of life..
- Stempeutics partners with Cipla for diabetic foot ulcer treatment product.
Under the agreement, Cipla will get exclusive marketing rights for five years in India for the diabetic foot ulcer (DFU) product. Stempeutics will manufacture and supply the product to Indian company, the company said..
- Stempeutics, Kemwell in joint development and marketing pact for stem-cell products.
Kemwell will take a minority stake in Stempeutics and invest up to Rs 95 crore based on certain milestones as well as establish a world class cGMP cell therapy manufacturing  facility  at  Kemwell's  facility  in  Bengaluru..
- Stempeutics partners with Cipla for its stem cell drug.
Founded in 2006 by Manipal Education and Medical Group (MEMG), Stempeutics later entered into an alliance with Cipla in 2009. It is an advanced clinical stage biotech firm..
Frequently asked questions
What is the Incorporation or founding date of Stempeutics Research Private Limited?
Stempeutics Research Private Limited was incorporated on 16 Jan 2006.
What is authorized share capital and paid-up capital of Stempeutics Research Private Limited?
The authorized share capital of Stempeutics Research Private Limited is ₹ 65.00 Cr and paid-up capital is ₹ 59.67 Cr.
Who are the current board members & directors of Stempeutics Research Private Limited?
Currently 6 directors are associated with Stempeutics Research Private Limited.
- Anurag Bagaria
- Manohar Balu Narasimhan
- Hebri Sudarshan Ballal
- Umang Vohra
- Jaideep Ashok Gogtay
- Kriti Agarwal
What is the registered address of Stempeutics Research Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Stempeutics Research Private Limited is 3Rd Floor 143 212-215 Epip Industrial Area Hoodi Village K.R.Puram, Hobli India, Bengaluru, Karnataka, 560066.
What is the corporate identification number (CIN) and company number of Stempeutics Research Private Limited?
The corporate identification number (CIN) of Stempeutics Research Private Limited is U73100KA2006PTC038256 and the company number is 038256 as per Ministry of Corporate Affairs (MCA).
What is the official website of Stempeutics Research Private Limited?
The Official website of Stempeutics Research Private Limited is https://www.stempeutics.com
What has been the recent revenue trend for Stempeutics Research Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Stempeutics Research Private Limited has risen by 357.64%.
How many employees does Stempeutics Research Private Limited currently have?
As Per 2023 financial reports, 27 employees are currently employed by Stempeutics Research Private Limited.
What change has been observed in the net worth of Stempeutics Research Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Stempeutics Research Private Limited has experienced an upsurge of 52.97%.
What are the total open charges for Stempeutics Research Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Stempeutics Research Private Limited amount to ₹ 2.18 Cr.
When was the last Balance Sheet of Stempeutics Research Private Limited filed with the ROC?
The most recent Balance Sheet for Stempeutics Research Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Vikram PenuboluDirector
Steven LehrerDirector
Satish ToteyDirector
Chandru ChawlaDirectorRP
Ramdas PaiDirector and DirectorCM
Chandrasekaran MahadevanDirectorRP
Ramdas PaiDirector and DirectorSB
Subhaskrishna BallalDirector
Similar Companies Based on Biotechnology
Venkateshwara B.V. Biocorp Private Limited Pune, Maharashtra, India
Sanofi Healthcare India Private Limited Mumbai, Maharashtra, India
Biotechnology Industry Research Assistance Council Delhi, India
Invitrogen Bioservices India Private Limited Bangaluru, Karnataka, India
Ecso Global Private Limited New Delhi, India
Gennova Biopharmaceuticals Limited Pune, Maharashtra, India
Aurigene Oncology Limited Bangaluru, Karnataka, India